This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Olumiant
  • /
  • A Study of Baricitinib (LY3009104) in Participants...
Clinical trial

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (BRAVE I)

Read time: 1 mins
Last updated:19th Jan 2021
Status: Recruiting
Identifier: NCT03616912
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest